Option Care Health, Inc. (NASDAQ:OPCH) Sees Significant Decrease in Short Interest

Option Care Health, Inc. (NASDAQ:OPCHGet Free Report) was the target of a large decrease in short interest in December. As of December 31st, there was short interest totalling 3,800,000 shares, a decrease of 34.8% from the December 15th total of 5,830,000 shares. Based on an average daily trading volume, of 2,120,000 shares, the short-interest ratio is currently 1.8 days. Currently, 2.3% of the shares of the stock are sold short.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on OPCH. Barrington Research cut their price target on Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a research note on Thursday, October 31st. UBS Group assumed coverage on shares of Option Care Health in a research report on Thursday, December 5th. They set a “neutral” rating and a $26.00 price target for the company. Jefferies Financial Group lowered shares of Option Care Health from a “buy” rating to a “hold” rating and cut their price objective for the company from $38.00 to $26.00 in a report on Thursday, October 31st. Bank of America raised shares of Option Care Health from a “neutral” rating to a “buy” rating and lifted their target price for the stock from $26.00 to $33.00 in a report on Monday. Finally, The Goldman Sachs Group downgraded Option Care Health from a “buy” rating to a “neutral” rating and cut their price target for the company from $38.00 to $27.00 in a research note on Monday, November 4th. Three equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Option Care Health presently has a consensus rating of “Moderate Buy” and a consensus target price of $29.71.

View Our Latest Analysis on OPCH

Insider Buying and Selling

In other news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of Option Care Health stock in a transaction on Friday, November 8th. The shares were purchased at an average price of $22.54 per share, with a total value of $969,220.00. Following the acquisition, the director now owns 326,334 shares in the company, valued at $7,355,568.36. This represents a 15.18 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.64% of the stock is owned by corporate insiders.

Institutional Trading of Option Care Health

Several hedge funds have recently bought and sold shares of OPCH. American Century Companies Inc. raised its holdings in shares of Option Care Health by 0.5% during the second quarter. American Century Companies Inc. now owns 1,154,215 shares of the company’s stock worth $31,972,000 after acquiring an additional 5,614 shares during the period. Federated Hermes Inc. raised its stake in shares of Option Care Health by 5.5% in the 2nd quarter. Federated Hermes Inc. now owns 20,621 shares of the company’s stock valued at $571,000 after purchasing an additional 1,073 shares during the period. Oppenheimer Asset Management Inc. lifted its holdings in shares of Option Care Health by 15.4% in the second quarter. Oppenheimer Asset Management Inc. now owns 65,075 shares of the company’s stock valued at $1,803,000 after purchasing an additional 8,695 shares in the last quarter. Envestnet Asset Management Inc. boosted its position in shares of Option Care Health by 2.8% during the second quarter. Envestnet Asset Management Inc. now owns 231,315 shares of the company’s stock worth $6,407,000 after buying an additional 6,283 shares during the period. Finally, Massachusetts Financial Services Co. MA bought a new position in shares of Option Care Health during the second quarter worth about $68,003,000. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Option Care Health Stock Up 15.5 %

Shares of Option Care Health stock opened at $27.72 on Tuesday. The company has a market capitalization of $4.72 billion, a P/E ratio of 23.29, a price-to-earnings-growth ratio of 2.43 and a beta of 1.31. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The business has a 50-day moving average of $23.20 and a two-hundred day moving average of $27.69. Option Care Health has a 1 year low of $21.39 and a 1 year high of $34.63.

About Option Care Health

(Get Free Report)

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

Featured Articles

Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.